Senores Pharmaceutic Stock Price Analysis and Quick Research Report. Is Senores Pharmaceutic an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Senores Pharmaceutic. 

• PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Senores Pharmaceutic has a PE ratio of 347.743150175891 which is high and comparatively overvalued.

• Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Senores Pharmaceutic has ROA of 2.3544% which is a bad sign for future performance. (Higher values are always desirable.)

• Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Senores Pharmaceutic has a Current ratio of 3.6746.

• Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Senores Pharmaceutic has a ROE of 2.7786%. (Higher is better)

• Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. Senores Pharmaceutic has a Debt to Equity ratio of 0.0954 which means that the company has low proportion of debt in its capital.

• Sales growth: Senores Pharmaceutic has reported revenue growth of 175.2724% which is fair in relation to its growth and performance. 

• Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of Senores Pharmaceutic for the current financial year is -17.6076915826185%.

• Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Senores Pharmaceutic is Rs 0 and the yield is 0%.

• Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Senores Pharmaceutic is Rs 4.0366. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Senores Pharmaceutic in Ticker for free. Also, one can get the intrinsic value of Senores Pharmaceutic by using Valuation Calculators, which are available with a Finology ONE subscription. 

Senores Pharmaceutic FAQs

Q1. What is Senores Pharmaceutic share price today?
Ans: The current share price of Senores Pharmaceutic is Rs 1403.7.

Q2. What is the market capitalisation of Senores Pharmaceutic?
Ans: Senores Pharmaceutic has a market capitalisation of Rs 6464.54214756 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of Senores Pharmaceutic?
Ans: The PE ratio of Senores Pharmaceutic is 347.743150175891 and the P/B ratio of Senores Pharmaceutic is 8.61222706780572, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of Senores Pharmaceutic share?
Ans: The 52-week high share price of Senores Pharmaceutic is Rs 1599, and the 52-week low share price of Senores Pharmaceutic is Rs 684.6.

Q5. Does Senores Pharmaceutic pay dividends?
Ans: Currently, Senores Pharmaceutic does not pay dividends. Dividend yield of Senores Pharmaceutic is around 0%.

Q6. What are the face value and book value of Senores Pharmaceutic shares?
Ans: The face value of Senores Pharmaceutic shares is Rs 10, while the book value per share of Senores Pharmaceutic is around Rs 162.9892. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of Senores Pharmaceutic?
Ans: Senores Pharmaceutic has a total debt of Rs 71.52 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of Senores Pharmaceutic?
Ans: The ROE of Senores Pharmaceutic is 2.7786% and ROCE of Senores Pharmaceutic is 4.2431%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is Senores Pharmaceutic a good buy for the long term?
Ans: The Senores Pharmaceutic long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is Senores Pharmaceutic undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the Senores Pharmaceutic appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check Senores Pharmaceutic’s financials?
Ans: You can review Senores Pharmaceutic’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.